Paul L Berns insider trades
Open-market stock purchases and sales by Paul L Berns, Director, 10% Owner at Kardigan, Inc, from SEC Form 4 filings since Jan 8, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +292%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 22, 2026 | KARD Kardigan, Inc | Bought | $20M |
| Jun 17, 2026 | KARD Kardigan, Inc | Bought (not open market) | — |
| Jun 17, 2026 | KARD Kardigan, Inc | Bought (not open market) | — |
| Jun 17, 2026 | KARD Kardigan, Inc | Bought (not open market) | — |
| Jun 17, 2026 | KARD Kardigan, Inc | Bought (not open market) | — |
| Jun 17, 2026 | KARD Kardigan, Inc | Bought (not open market) | — |
| Feb 17, 2026 | NMRA Neumora Therapeutics, Inc | Sold | $34.5K |
| Jan 8, 2026 | NMRA Neumora Therapeutics, Inc | Bought (not open market) | — |
| Nov 13, 2025 | MTSR Metsera, Inc | Sold (not open market) | — |
| Nov 13, 2025 | MTSR Metsera, Inc | Sold (not open market) | — |
| Nov 13, 2025 | MTSR Metsera, Inc | Sold (not open market) | — |
| Nov 13, 2025 | MTSR Metsera, Inc | Sold (not open market) | — |
| Nov 13, 2025 | MTSR Metsera, Inc | Bought (not open market) | — |
| Nov 13, 2025 | MTSR Metsera, Inc | Sold (not open market) | $707K |
| Nov 13, 2025 | MTSR Metsera, Inc | Sold (not open market) | $1.8M |
Companies traded
- KARD Kardigan, Inc: 1 buy, last Jun 22, 2026
- NMRA Neumora Therapeutics, Inc: 2 sales, last Feb 17, 2026
- MTSR Metsera, Inc: 1 buy, last Nov 13, 2025
- UBX Unity Biotechnology, Inc: other filings, last Jun 21, 2024
- EQRX EQRx, Inc: other filings, last Nov 9, 2023
- JAZZ Jazz Pharmaceuticals plc: 15 sales, last Aug 5, 2021
- MNLO Menlo Therapeutics Inc: other filings, last Jun 25, 2019
- ANAC Anacor Pharmaceuticals, Inc: 26 sales, last Jun 24, 2016
- XNPT Xenoport Inc: 2 sales, last May 17, 2016
- CLRB Cellectar Biosciences, Inc: 1 buy, last Apr 20, 2016
- ALTH Allos Therapeutics Inc: 12 sales, last Sep 4, 2012